Our study also identified a novel mechanism by which PTEN induced p21 expression in pancreatic cancer cells; this could contribute to the interaction with ANKHD1 and inhibit binding to the p21 promoter of ANKHD1. Here, CDKN1A is linked to pancreatic neoplasm.